STOCK TITAN

Insider to sell 1,743 shares of Issuer (NYSE: PHR) stock after restricted stock vests

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

The issuer of PHR common stock has filed a Form 144 for a planned sale of 1,743 common shares. The shares are expected to be sold on the NYSE through Fidelity Brokerage Services LLC, with an aggregate market value indicated as $28,549.47.

The 1,743 shares were acquired on January 14, 2026 through restricted stock vesting as compensation from the issuer, with payment also dated January 14, 2026. The notice also lists other recent sales in the past three months by individuals named David Linetsky and Jessica Weiss, including blocks of 2,059 and 6,106 common shares, with gross proceeds such as $46,041.71 and $103,845.36.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the PHR Form 144 filing disclose?

The Form 144 discloses an intent to sell 1,743 shares of PHR common stock on the NYSE, with an indicated aggregate market value of $28,549.47.

How were the 1,743 PHR shares being sold acquired?

The 1,743 common shares were acquired on January 14, 2026 through restricted stock vesting from the issuer as compensation.

Which broker is handling the planned PHR share sale in this Form 144?

The planned sale is to be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.

On which exchange will the 1,743 PHR shares be sold and when?

The filing indicates an approximate sale date of January 15, 2026 and lists the NYSE as the securities exchange for the sale of the 1,743 shares.

What recent PHR stock sales are listed for the past 3 months?

The filing lists sales of PHR common stock by David Linetsky and Jessica Weiss, including transactions such as 2,059 shares on October 17, 2025 for $46,041.71 and 6,106 shares on January 8, 2026 for $103,845.36.

What representation does the seller make in the PHR Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Phreesia

NYSE:PHR

PHR Rankings

PHR Latest News

PHR Latest SEC Filings

PHR Stock Data

971.22M
57.09M
4.19%
99.86%
4.91%
Health Information Services
Services-business Services, Nec
Link
United States
WILMINGTON